BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2451894)

  • 1. Effects of interferons alpha,beta,gamma alone or in combination on the phenotype of human colon carcinoma cells.
    Brouty-Boyé D; Maunoury MT; Lowy R
    Anticancer Res; 1988; 8(1):197-203. PubMed ID: 2451894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic antiproliferative effect of recombinant alpha-interferons with recombinant gamma-interferon.
    Hubbell HR; Craft JA; Leibowitz PJ; Gillespie DH
    J Biol Response Mod; 1987 Apr; 6(2):141-53. PubMed ID: 3108460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines.
    Schiller JH; Bittner G; Storer B; Willson JK
    Cancer Res; 1987 Jun; 47(11):2809-13. PubMed ID: 3105867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects.
    Wadler S; Wersto R; Weinberg V; Thompson D; Schwartz EL
    Cancer Res; 1990 Sep; 50(18):5735-9. PubMed ID: 1697499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses.
    Sidky YA; Borden EC
    Cancer Res; 1987 Oct; 47(19):5155-61. PubMed ID: 2441862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of recombinant human interferon-beta and interferon-gamma in combination against human colon cancer cell line in vitro and in nude mice.
    Kondo H; Tanaka N; Naomoto Y; Orita K
    Jpn J Cancer Res; 1987 Nov; 78(11):1258-65. PubMed ID: 3121561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alpha and gamma interferons and cytostatics on ovarian cancer in the subrenal capsule assay.
    Grönroos M; Mäenpää J; Söderström KO; Kangas L; Leppänen M; Cantell K
    Med Biol; 1983; 61(5):275-9. PubMed ID: 6200736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced in vitro growth suppression of human glioblastoma cultures treated with the combination of recombinant fibroblast and immune interferons.
    Vita JR; Edwalds GM; Gorey T; Housepian EM; Fetell MR; Guarini L; Langer JA; Fisher PB
    Anticancer Res; 1988; 8(3):297-302. PubMed ID: 2839097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
    Lindner DJ; Borden EC; Kalvakolanu DV
    Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical modulation of 5-fluorouracil with interferon alpha/beta and gamma on murine renal cell carcinoma.
    Ishii T; Marumo K
    Int J Urol; 2004 Nov; 11(11):993-1000. PubMed ID: 15509204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between human and porcine interferons.
    Filipic B; Golob A; Tóth S; Mécs I; Béládi I; Likar M
    Acta Virol; 1991 Jan; 35(1):19-26. PubMed ID: 1719784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of IL-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells: role for endogenous IFN-beta.
    Dansky-Ullmann C; Salgaller M; Adams S; Schlom J; Greiner JW
    Cytokine; 1995 Feb; 7(2):118-29. PubMed ID: 7780031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hyperthermia on the antiproliferative activities of murine alpha-, beta-, and gamma-interferon: differential enhancement of murine gamma-interferon.
    Fleischmann WR; Fleischmann CM; Gindhart TD
    Cancer Res; 1986 Jan; 46(1):8-13. PubMed ID: 2998611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
    Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
    Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of antiviral and anticellular activities of human recombinant interferon-gamma.
    Gomi K; Morimoto M; Nakamizo N
    Jpn J Cancer Res; 1985 Mar; 76(3):224-34. PubMed ID: 3922841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid or methionine enhance interferon's inhibition of the transformed phenotype with no effect on tumorigenicity.
    Brouty-Boyé D; Lejealle R
    J Biol Regul Homeost Agents; 1988; 2(1):45-9. PubMed ID: 3177023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential antiproliferative activities of IFNs alpha, beta and gamma: kinetics of establishment of their antiproliferative effects and the rapid development of resistance to IFNs alpha and beta.
    Fleischmann CM; Fleischmann WR
    J Biol Regul Homeost Agents; 1988; 2(4):173-85. PubMed ID: 3150645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of the direct anticellular activity of mouse interferons: mutual synergism and interferon concentration dependence.
    Fleischmann WR
    Cancer Res; 1982 Mar; 42(3):869-75. PubMed ID: 6174218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent sensitivity of human tumor cell lines to interferon and double-stranded RNA.
    Hubbell HR; Liu RS; Maxwell BL
    Cancer Res; 1984 Aug; 44(8):3252-7. PubMed ID: 6204744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
    Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
    Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.